Key facts
- AMICUS THERAPEUTICS, INC. has 17 insiders with reported activity on this page.
- Net insider value flow over the last year: -$5,414,949.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 17 Insiders of AMICUS THERAPEUTICS, INC.
- Location
- Princeton, NJ
Change
- Buy value: ; sell value: $5,414,949.
- Net share flow: -478,950.
Research use
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$5,414,949.
Buys
$0
Shares: 0
Insiders: 0
Sells
$5,414,949
Shares: 478,950
Insiders: 4
Net
-$5,414,949
Shares: -478,950
Insiders: -4
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 22,500 | $0 | $322,839 | -$322,839 |
| 3-6 | 0 | 430,807 | $0 | $4,848,250 | -$4,848,250 |
| 6-9 | 0 | 25,643 | $0 | $243,860 | -$243,860 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
AMICUS THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| John F. Crowley | Executive Chairman, Director | $8,521,769 | Mixed | 01 Mar 2024 | ||
| Daphne Quimi | Chief Financial Officer | $4,926,692 | Mixed | 17 Jan 2023 | ||
| Robert Essner | Director | $384,647 | Mixed | 10 Jun 2021 | ||
| Simon N.r. Harford | Chief Financial Officer | $0 | Mixed | 27 Apr 2026 | ||
| Michael Raab | Director | $0 | Mixed | 27 Apr 2026 | ||
| Lynn Dorsey Bleil | Director | $0 | Mixed | 27 Apr 2026 | ||
| Jeff Castelli | Chief Development Officer | $0 | -$773,659 | -100% | Mixed | 27 Apr 2026 |
| Eiry Roberts | Director | $0 | Mixed | 27 Apr 2026 | ||
| Burke W. Whitman | Director | $0 | Mixed | 27 Apr 2026 | ||
| Michael Aaron Kelly | Director | $0 | Mixed | 27 Apr 2026 | ||
| Margaret G. Mcglynn | Director | $0 | Mixed | 27 Apr 2026 | ||
| Bradley L. Campbell | President and CEO, Director | $0 | -$2,534,566 | -100% | Mixed | 27 Apr 2026 |
| David Michael Clark | Chief People Officer | $0 | -$1,148,246 | -100% | Mixed | 27 Apr 2026 |
| Samantha Prout | Chief Accounting Officer | $0 | Mixed | 27 Apr 2026 | ||
| Ellen Rosenberg | Chief Legal Officer | $0 | -$958,478 | -100% | Mixed | 27 Apr 2026 |
| Craig A. Wheeler | Director | $0 | Mixed | 27 Apr 2026 | ||
| Glenn Sblendorio | Director | $0 | Mixed | 27 Apr 2026 |
Top shareholders of AMICUS THERAPEUTICS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.4%
from 13D/G
|
33,879,048
|
$489,891,036 | — | 31 Mar 2026 | |
| UBS Group AG |
13D/G
13F
|
Company |
5.5%
|
17,141,817
|
$247,870,674 | $0 | 31 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13D/G
13F
|
THE GOLDMAN SACHS GROUP, INC. · Company |
5.3%
|
16,782,163
|
$242,670,074 | $0 | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Vanguard Capital Management · Company |
5.2%
|
16,350,837
|
$236,433,103 | $0 | 31 Mar 2026 | |
| Avoro Capital Advisors LLC |
13D/G
|
— |
4.9%
|
15,025,000
|
$118,397,000 | -$43,143,000 | 30 Sep 2025 | |
| Redmile Group, LLC |
13D/G
|
— |
4.6%
|
14,184,495
|
$106,667,402 | $0 | 31 Dec 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13D/G
|
— |
3.4%
|
10,627,717
|
$151,763,799 | -$76,348,548 | 31 Dec 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
|
— |
2.4%
|
7,412,830
|
$43,290,927 | -$82,061,910 | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
|
— |
0.4%
|
1,373,867
|
$19,618,821 | -$386,818,454 | 31 Dec 2025 | |
| Pentwater Capital Management LP |
13F
|
Company |
4.4%
|
14,000,000
|
$202,440,000 | — | 31 Mar 2026 | |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
|
Company |
4.4%
|
13,974,932
|
$202,077,517 | — | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
4.1%
|
12,893,897
|
$186,445,751 | — | 31 Mar 2026 | |
| GLAZER CAPITAL, LLC |
13F
|
Company |
4%
|
12,722,749
|
$183,971,000 | — | 31 Mar 2026 | |
| FIL Ltd |
13F
|
Company |
4%
|
12,560,028
|
$181,618,005 | — | 31 Mar 2026 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
2.8%
|
8,809,340
|
$127,383,056 | — | 31 Mar 2026 | |
| HBK INVESTMENTS L P |
13F
|
Company |
2.8%
|
8,783,448
|
$127,008,658 | — | 31 Mar 2026 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.7%
|
8,535,918
|
$123,452,195 | — | 31 Mar 2026 | |
| O'Connor Alternative Investments LLC |
13F
|
Company |
2.7%
|
8,444,992
|
$122,114,584 | — | 31 Mar 2026 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.5%
|
7,908,459
|
$114,356,317 | — | 31 Mar 2026 | |
| MORGAN STANLEY |
13F
|
Company |
2.2%
|
6,998,884
|
$101,203,875 | — | 31 Mar 2026 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.1%
|
6,749,190
|
$97,390,812 | — | 31 Mar 2026 | |
| AQR Arbitrage LLC |
13F
|
Company |
1.8%
|
5,843,849
|
$84,502,057 | — | 31 Mar 2026 | |
| SOROS FUND MANAGEMENT LLC |
13F
|
Company |
1.8%
|
5,753,186
|
$83,191,070 | — | 31 Mar 2026 | |
| Kryger Capital LLC |
13F
|
Company |
1.4%
|
4,554,174
|
$65,853,356 | — | 31 Mar 2026 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.4%
|
4,316,272
|
$61,463,713 | — | 31 Mar 2026 | |
| CITIGROUP INC |
13F
|
Company |
1.3%
|
4,226,882
|
$61,120,714 | — | 31 Mar 2026 | |
| Magnetar Financial LLC |
13F
|
Company |
1.3%
|
3,986,058
|
$57,638,399 | — | 31 Mar 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.2%
|
3,899,490
|
$56,386,624 | — | 31 Mar 2026 | |
| Weiss Asset Management LP |
13F
|
Company |
1.2%
|
3,872,902
|
$56,002,163 | — | 31 Mar 2026 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1.2%
|
3,827,513
|
$55,345,838 | — | 31 Mar 2026 | |
| TIG Advisors, LLC |
13F
|
Company |
1.2%
|
3,825,445
|
$55,315,935 | — | 31 Mar 2026 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
1.2%
|
3,643,352
|
$52,682,870 | — | 31 Mar 2026 | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. |
13F
|
Company |
1.1%
|
3,559,972
|
$51,477,000 | — | 31 Mar 2026 | |
| Capula Management Ltd |
13F
|
Company |
1%
|
3,191,610
|
$46,150,680 | — | 31 Mar 2026 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.86%
|
2,720,444
|
$39,337,619 | — | 31 Mar 2026 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.79%
|
2,514,240
|
$36,355,910 | — | 31 Mar 2026 | |
| Nuveen, LLC |
13F
|
Company |
0.73%
|
2,300,567
|
$33,266,198 | — | 31 Mar 2026 | |
| VANGUARD FIDUCIARY TRUST CO |
13F
|
Company |
0.68%
|
2,139,129
|
$30,931,805 | — | 31 Mar 2026 | |
| NEXPOINT ASSET MANAGEMENT, L.P. |
13F
|
Company |
0.64%
|
2,039,280
|
$29,487,989 | — | 31 Mar 2026 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.59%
|
1,872,893
|
$27,082,033 | — | 31 Mar 2026 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.59%
|
1,864,602
|
$26,962,145 | — | 31 Mar 2026 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.56%
|
1,757,899
|
$25,419,218 | — | 31 Mar 2026 | |
| FMR LLC |
13F
|
Company |
0.55%
|
1,753,843
|
$25,360,567 | — | 31 Mar 2026 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.54%
|
1,705,829
|
$24,666,287 | — | 31 Mar 2026 | |
| CIBRA Capital Ltd |
13F
|
Company |
0.53%
|
1,687,661
|
$24,403,578 | — | 31 Mar 2026 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.52%
|
1,650,000
|
$23,859,000 | — | 31 Mar 2026 | |
| ALPINE ASSOCIATES MANAGEMENT INC. |
13F
|
Company |
0.5%
|
1,596,190
|
$23,080,907 | — | 31 Mar 2026 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.49%
|
1,543,000
|
$22,311,780 | — | 31 Mar 2026 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.46%
|
1,441,683
|
$20,846,736 | — | 31 Mar 2026 | |
| GARDNER LEWIS ASSET MANAGEMENT L P |
13F
|
Company |
0.45%
|
1,414,748
|
$20,457,256 | — | 31 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for AMICUS THERAPEUTICS, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Craig A. Wheeler | FOLD | Common Stock | Disposed to Issuer | -100% | -84,631 | 0 | 27 Apr 2026 | Direct | ||
| Craig A. Wheeler | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -313,630 | 0 | 27 Apr 2026 | Direct | ||
| Margaret G. Mcglynn | FOLD | Common Stock | Disposed to Issuer | -100% | -94,631 | 0 | 27 Apr 2026 | Direct | ||
| Margaret G. Mcglynn | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -303,630 | 0 | 27 Apr 2026 | Direct | ||
| Burke W. Whitman | FOLD | Common Stock | Disposed to Issuer | -100% | -118,598 | 0 | 27 Apr 2026 | Direct | ||
| Burke W. Whitman | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -273,885 | 0 | 27 Apr 2026 | Direct | ||
| Glenn Sblendorio | FOLD | Common Stock | Disposed to Issuer | -100% | -142,564 | 0 | 27 Apr 2026 | Direct | ||
| Glenn Sblendorio | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -303,630 | 0 | 27 Apr 2026 | Direct | ||
| Eiry Roberts | FOLD | Common Stock | Disposed to Issuer | -100% | -76,275 | 0 | 27 Apr 2026 | Direct | ||
| Eiry Roberts | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -233,861 | 0 | 27 Apr 2026 | Direct | ||
| Lynn Dorsey Bleil | FOLD | Common Stock | Disposed to Issuer | -100% | -113,941 | 0 | 27 Apr 2026 | Direct | ||
| Lynn Dorsey Bleil | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -281,999 | 0 | 27 Apr 2026 | Direct | ||
| Michael Aaron Kelly | FOLD | Common Stock | Disposed to Issuer | -100% | -72,468 | 0 | 27 Apr 2026 | Direct | ||
| Michael Aaron Kelly | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -229,347 | 0 | 27 Apr 2026 | Direct | ||
| Michael Raab | FOLD | Common Stock | Disposed to Issuer | -100% | -115,857 | 0 | 27 Apr 2026 | Direct | ||
| Michael Raab | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -303,630 | 0 | 27 Apr 2026 | Direct | ||
| Samantha Prout | FOLD | Common Stock | Disposed to Issuer | -100% | -125,951 | 0 | 27 Apr 2026 | Direct | ||
| Samantha Prout | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -205,022 | 0 | 27 Apr 2026 | Direct | ||
| Jeff Castelli | FOLD | Common Stock | Disposed to Issuer | -100% | -427,089 | 0 | 27 Apr 2026 | Direct | ||
| Jeff Castelli | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -673,537 | 0 | 27 Apr 2026 | Direct | ||
| David Michael Clark | FOLD | Common Stock | Disposed to Issuer | -100% | -221,811 | 0 | 27 Apr 2026 | Direct | ||
| David Michael Clark | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -675,720 | 0 | 27 Apr 2026 | Direct | ||
| Ellen Rosenberg | FOLD | Common Stock | Disposed to Issuer | -100% | -15,000 | 0 | 27 Apr 2026 | By Spouse | ||
| Ellen Rosenberg | FOLD | Common Stock | Disposed to Issuer | -100% | -463,898 | 0 | 27 Apr 2026 | Direct | ||
| Ellen Rosenberg | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -786,095 | 0 | 27 Apr 2026 | Direct | ||
| Simon N.r. Harford | FOLD | Common Stock | Disposed to Issuer | -100% | -143,595 | 0 | 27 Apr 2026 | Direct | ||
| Simon N.r. Harford | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -438,633 | 0 | 27 Apr 2026 | Direct | ||
| Bradley L. Campbell | FOLD | Common Stock | Disposed to Issuer | -100% | -1,008,680 | 0 | 27 Apr 2026 | Direct | ||
| Bradley L. Campbell | FOLD | Stock Options (right to buy) | Disposed to Issuer | -100% | -1,964,409 | 0 | 27 Apr 2026 | Direct | ||
| Bradley L. Campbell | FOLD | Common Stock | Sale | -2.2% | $322,839 | $14.35 | -22,500 | 998,680 | 02 Mar 2026 | Direct |
| Bradley L. Campbell | FOLD | Common Stock | Sale | -6.84% | $1,073,182 | $14.31 | -75,000 | 1,021,180 | 20 Jan 2026 | Direct |
| Bradley L. Campbell | FOLD | Common Stock | Options Exercise | 7.34% | 75,000 | 1,096,180 | 20 Jan 2026 | Direct | ||
| Bradley L. Campbell | FOLD | Stock Options (right to buy) | Options Exercise | -100% | -75,000 | 0 | 20 Jan 2026 | Direct | ||
| Ellen Rosenberg | FOLD | Common Stock | Tax liability | -6.01% | -29,683 | 464,601 | 03 Jan 2026 | Direct | ||
| Jeff Castelli | FOLD | Common Stock | Tax liability | -5.34% | -23,102 | 409,311 | 03 Jan 2026 | Direct | ||
| Samantha Prout | FOLD | Common Stock | Tax liability | -8.86% | -12,240 | 125,951 | 03 Jan 2026 | Direct | ||
| David Michael Clark | FOLD | Common Stock | Tax liability | -7.7% | -18,498 | 221,811 | 03 Jan 2026 | Direct | ||
| Ellen Rosenberg | FOLD | Common Stock | Tax liability | -2.64% | -13,426 | 494,284 | 02 Jan 2026 | Direct | ||
| Jeff Castelli | FOLD | Common Stock | Tax liability | -1.57% | -6,905 | 432,413 | 02 Jan 2026 | Direct | ||
| Samantha Prout | FOLD | Common Stock | Tax liability | -2.43% | -3,443 | 138,191 | 02 Jan 2026 | Direct | ||
| David Michael Clark | FOLD | Common Stock | Tax liability | -2.19% | -5,381 | 240,309 | 02 Jan 2026 | Direct | ||
| Bradley L. Campbell | FOLD | Common Stock | Tax liability | -9.61% | -108,602 | 1,021,180 | 26 Dec 2025 | Direct | ||
| Simon N.r. Harford | FOLD | Common Stock | Tax liability | -33.2% | -71,303 | 143,595 | 26 Dec 2025 | Direct | ||
| David Michael Clark | FOLD | Common Stock | Sale | -9.45% | $363,380 | $14.17 | -25,642 | 245,690 | 19 Dec 2025 | Direct |
| Bradley L. Campbell | FOLD | Common Stock | Sale | -6.45% | $846,011 | $10.86 | -77,926 | 1,129,782 | 15 Dec 2025 | Direct |
| Bradley L. Campbell | FOLD | Common Stock | Options Exercise | 6.19% | 70,426 | 1,207,708 | 15 Dec 2025 | Direct | ||
| Bradley L. Campbell | FOLD | Stock Options (right to buy) | Options Exercise | -100% | -70,426 | 0 | 15 Dec 2025 | Direct | ||
| David Michael Clark | FOLD | Common Stock | Sale | -8.63% | $282,073 | $11.00 | -25,643 | 271,332 | 15 Dec 2025 | Direct |
| Bradley L. Campbell | FOLD | Common Stock | Sale | -1.27% | $146,011 | $10.01 | -14,587 | 1,137,282 | 01 Dec 2025 | Direct |
| Bradley L. Campbell | FOLD | Common Stock | Options Exercise | 1.28% | 14,587 | 1,151,869 | 01 Dec 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.